Top

Published in:

Open Access 01-12-2023 | Breast Cancer | Letter

Patient and Public Involvement (PPI) in outcome selection in breast cancer and nephrology trials

Authors: Ciara Buckley, Shaun Treweek, Lynn Laidlaw, Frances Shiely

Published in: Trials | Issue 1/2023

Abstract

We recently reported that according to patients and healthcare professionals in breast cancer and nephrology trials, teams conducting the trials got their choice of primary outcome wrong (72% of the time) more often than they got it right (28% of the time). A Patient and Public Involvement (PPI) representative, co-author of this letter, asked (on Twitter) whether PPI contributors had been involved in the design of the original trials and by extension the outcome selection. The purpose of this study was to answer this question.

Treweek S, Miyakoda V, Burke D, Shiely F. Getting it wrong most of the time? Comparing trialists’ choice of primary outcome with what patients and health professionals want. Trials. 2022;23(1):537.CrossRef

Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. Int J Surg. 2012;10(1):28–55.CrossRef

Bagley HJ, Short H, Harman NL, Hickey HR, Gamble CL, Woolfall K, et al. A patient and public involvement (PPI) toolkit for meaningful and flexible involvement in clinical trials–a work in progress. Res Involv Engagem. 2016;2(1):1–14.CrossRef

Sacristán JA, Aguarón A, Avendaño-Solá C, Garrido P, Carrión J, Gutiérrez A, et al. Patient involvement in clinical research: why, when, and how. Patient Prefer Adherence. 2016;10:631.CrossRef

Papoulias S, Constantina), Callard F. “A limpet on a ship”: spatio-temporal dynamics of patient and public involvement in research. Health Expect. 2021;24(3):810–8.CrossRef

Pirosca S, Shiely F, Clarke M, Treweek S. Tolerating bad health research: the continuing scandal. Trials. 2022;23(1):458.CrossRef

Knowles SE, Allen D, Donnelly A, Flynn J, Gallacher K, Lewis A, et al. More than a method: trusting relationships, productive tensions, and two-way learning as mechanisms of authentic co-production. Res Involv Engagem. 2021;7(1):34.CrossRef

Locock L, Boylan AM, Snow R, Staniszewska S. The power of symbolic capital in patient and public involvement in health research. Health Expect. 2017;20(5):836–44.CrossRef

Ocloo J, Matthews R. From tokenism to empowerment: progressing patient and public involvement in healthcare improvement. BMJ Qual Saf. 2016;25(8):626–32.CrossRef

10.

Staniszewska S, Brett J, Simera I, Seers K, Mockford C, Goodlad S, et al. GRIPP2 reporting checklists: tools to improve reporting of patient and public involvement in research. BMJ. 2017;358:j3453.CrossRef

11.

Scholz B, Bevan A. Toward more mindful reporting of patient and public involvement in healthcare. Res Involv Engagem. 2021;7(1):61.CrossRef

12.

Oliver S, Armes DG, Gyte G. Public involvement in setting a national research agenda. Patient Patient-Centered Outcomes Res. 2009;2(3):179–90.CrossRef

13.

Abma TA. Patient participation in health research: research with and for people with spinal cord injuries. Qual Health Res. 2005;15(10):1310–28.CrossRef

14.

Oliver S, Clarke-Jones L, Rees R, Milne R, Buchanan P, Gabbay J, et al. Involving consumers in research and development agenda setting for the NHS: developing an evidence-based approach; 2004.

15.

Sutton J, Weiss M. Involving patients as advisors in pharmacy practice research: what are the benefits? Int J Pharm Pract. 2008;16(4):231–8.CrossRef

16.

Staniszewska S, Herron-Marx S, Mockford C. Measuring the impact of patient and public involvement: the need for an evidence base. Int J Qual Health Care. 2008;20(6):373–4.CrossRef

17.

NIHR. National standards for public involvement. London: INVOLVE; 2018.

Title: Patient and Public Involvement (PPI) in outcome selection in breast cancer and nephrology trials
Authors: Ciara Buckley
Shaun Treweek
Lynn Laidlaw
Frances Shiely
Publication date: 01-12-2023
Publisher: BioMed Central
Keywords: Breast Cancer
Breast Cancer
Published in: Trials / Issue 1/2023
Electronic ISSN: 1745-6215
DOI: https://doi.org/10.1186/s13063-022-06980-9

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Patient and Public Involvement (PPI) in outcome selection in breast cancer and nephrology trials

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2023

Assessment of radio(chemo)therapy-related dysphagia in head and neck cancer patients based on cough-related acoustic features: a prospective phase II national clinical trial (ACCOUGH-P/A trial)

Rating versus ranking in a Delphi survey: a randomized controlled trial

Glycaemic control using mobile-based intervention in patients with diabetes undergoing coronary artery bypass—study protocol for a randomized controlled trial

Randomized controlled trial evaluating a virtual parenting intervention for young children at risk of obesity: study protocol for Parenting Addressing Early Years Intervention with Coaching Visits in Toronto (PARENT) trial

A cluster-randomized, placebo-controlled trial to evaluate the efficacy of a spatial repellent (Mosquito Shield™) against Aedes-borne virus infection among children ≥ 4–16 years of age in the Gampaha District, Sri Lanka: study protocol (the AEGIS program)

Protocol for a randomized controlled trial of endoscopic ultrasound guided celiac plexus neurolysis (EUS-CPN) with vs without bupivacaine